Efficacy and safety of bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia in the Asian subpopulation of the phase 3 BFORE trial

Charles Chuah, Liang Piu Koh, Tontanai Numbenjapon, Dae Young Zang, Kiat Hoe Ong, Young Rok Do, Masayuki Ohkura, Chiho Ono, Andrea Viqueira, Jorge E. Cortes, Tim H. Brümmendorf

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia in the Asian subpopulation of the phase 3 BFORE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences